The New Era of Personalized Glaucoma Care

In the AAO’s Glaucoma Subspecialty Day lecture, Dr. Friedman highlighted practical strategies and emerging technologies that can transform the identification, monitoring, and management of glaucoma.

David S. Friedman, MD, PhD, MPHJim Gallagher, senior managing editor

Glaucoma Physician October 18, 2025 Page(s): 19-20

Clinical Report: The New Era of Personalized Glaucoma Care

Overview

Dr. David S. Friedman emphasizes the importance of personalized glaucoma care, integrating genetics, patient-reported outcomes, and emerging technologies. This approach aims to improve diagnosis, treatment, and monitoring, addressing the significant number of undiagnosed glaucoma cases.

Background

Glaucoma remains a leading cause of irreversible blindness worldwide, with many patients undiagnosed or inadequately managed. Recent advancements in genetics and technology present opportunities to tailor glaucoma care to individual patient profiles, enhancing treatment efficacy and adherence. Understanding the psychosocial impacts of glaucoma is crucial for improving patient outcomes.

Data Highlights

Remove placeholder text and state that specific numerical data is not provided in the source.

Key Findings

Approximately half of glaucoma patients in the US remain undiagnosed.
Personalized care can utilize genetic profiles to predict disease progression and tailor treatments.
Patient-reported outcomes are essential for understanding the impact of glaucoma on daily life.
Selective laser trabeculoplasty (SLT) may be more effective than drops as a first-line therapy.
Emerging technologies, such as virtual reality-based testing, could enhance patient monitoring.

Clinical Implications

Clinicians should adopt a personalized approach to glaucoma management, considering genetic factors and patient lifestyles. Emphasizing adherence through education and alternative therapies can improve treatment outcomes. Regular monitoring and assessment of patient-reported outcomes are vital for effective management.

Conclusion

The shift towards personalized glaucoma care represents a significant advancement in the field, promising improved patient outcomes through tailored management strategies. Continued integration of technology and patient insights will be essential for future developments.

PentaVision

Glaucoma Physician